The physician makes the clinical decisions: the evaluation, the review of your options, and the recommended plan
Uses Elective use in adult patients with a BMI 25 for weight loss and metabolic optimization
Your provider adjusts dosing based on your individual response
This distinction has helped it stand out in a space that often leans heavily on unsubstantiated claims
GLP-1 receptor agonists also slow gastric emptying, reduce appetite through central nervous system pathways, and promote satiety, leading to reduced caloric intake and weight loss
The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genesmarkers that may reveal predisposition to metabolic response patterns